http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2012000594-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4d121c7abfaaeb49b0e383527ade50a |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 |
| filingDate | 2012-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7712a6034d9c9cd77ae6cf2d40fb3124 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1915c2a5ea58dc7331b7c8f960f1ff37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e360e61cf54825a92650514ce8fe4a7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04b487b90c9b2b37deea817a6d7a94cf |
| publicationDate | 2013-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CL-2012000594-A1 |
| titleOfInvention | Use of 2- (5-bromo-4- (4-cyclopropylnaphthalen-1-yl) -4h-1,2,4-triazol-3-ylthio) acetic acid to treat gout, hyperuricaemia and reduce serum uric acid; pharmaceutical composition; pharmaceutical combination; and salt of said compound. (application divisional 3529-08) |
| abstract | USE OF THE FORMULA 2- (5-BROMO-4 (4-CYCLOPROPYLNAPHTHALEN-1-IL) -4H-1, 2, 4-TRIAZOL-3-ITILIO) ACETIC ACID. TO TREAT Gout, HYPERURICEMIA AND REDUCE SERIC URIC ACID; PHARMACEUTICAL COMPOSITION; PHARMACEUTICAL COMBINATION; AND SALT OF SAID COMPOUND. |
| priorityDate | 2007-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.